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Abstract
The DosR regulon and the Enduring Hypoxic Response (EHR) define a group of M. tuberculosis genes that are specifically
induced in bacilli exposed in vitro to conditions thought to mimic the environment encountered by Mycobacteria during
latent infection. Although well described in humans, latent mycobacterial infection in cattle remains poorly understood.
Thus, the aim of this study was to identify antigens that may potentially disclose cattle with latent M. bovis infection. To this
end, we initially screened 57 pools of overlapping peptides representing 4 DosR regulon and 29 EHR antigens for their
ability to stimulate an immune response in whole blood from TB-reactor cattle using IFN-c and IL-2 as readouts. All 4 DosR
regulon proteins were poorly recognized (maximum responder frequency of 10%). For the EHR antigens, both IFN-c and IL-2
revealed similar response hierarchies, with responder frequencies ranging from 54% down to 3% depending on the given
EHR antigen. Furthermore, these results demonstrated that responses in the infected cattle were largely IFN-c biased. To
support the concept for their role in latency, we evaluated if EHR antigen responses were associated with lower pathology.
The EHR antigen Rv0188 was recognised predominantly in animals presenting with low pathology scores, whereas
responses to ESAT-6/CFP-10 or the other EHR antigens tested were prevalent across the pathology spectrum. However,
when we determined the production of additional cytokines induced by the M. bovis antigens PPD-B or ESAT-6/CFP-10, we
detected significantly greater PPD-B-induced production of the pro-inflammatory cytokine IL-1b in animals recognizing
Rv0188 (i.e. those with limited or no pathology). Thus, these results are consistent with the idea that responses to Rv0188
may identify a subset of animals at early stages of infection or in which disease progression may be limited.
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Introduction
Tuberculosis (TB) is a mycobacterial infection that affects
numerous species of mammals and poses a major global threat to
both public health and the farming industry. Following exposure
to Mycobacterium tuberculosis (M. tb), only a small percentage of
individuals (5 to 10%) will progress to a clinically active stage of
disease within the first two years, with symptoms including fever,
weight loss, coughing, the presence of acid-fast bacilli in sputa or
other clinical samples and abnormal chest radiographs. In
contrast, the majority of M. tb-infected individuals are able to
control disease progression through the induction of a robust cell-
mediated immune response. However, despite the absence of
clinical disease, mycobacteria remain viable in these individuals for
many years [1]. More importantly, these ‘‘latent’’ mycobacterial
infections have the potential to reactivate to active disease [2],
probably as a consequence of events resulting in host immuno-
supression [2,3,4]. Based on the tuberculin skin test, it is thought
that one-third of the world’s population is latently infected with M.
tb, which presents an enormous reservoir from which contagious
TB disease may arise.
Latent mycobacterial infection constitutes a complex interaction
between pathogen and host resulting in limited bacterial growth.
Studies in mice have demonstrated that inhibition of bacterial
growth in the lungs is preceded by increased expression of key
host-immunity genes, such as IFN-c and inducible nitric oxide
(NO) synthase-2 [5]. In vitro culture of tubercle bacilli in IFN-c-
activated macrophages, or in the presence of low-dose NO and
hypoxia (conditions thought to mimic those encountered by
mycobacteria during the latent stage of infection) results in
expression of a group of 48 genes known as the dormancy (DosR)
regulon [6,7]. More recently, studies in M. tb-infected individuals
have revealed that the gene products of several DosR regulon
genes are immunogenic, inducing T-cell proliferation and/or IFN-
c production [8,9,10,11]. Furthermore, immune responses to the
DosR antigen Rv2031c have been shown to be largely restricted to
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have shown conflicting results [14,15], the possible use of the
Rv2031c antigen as a diagnostic agent to differentiate between
active and latent disease remains unclear. In addition to the DosR
regulon, growth of mycobacteria in hypoxic conditions also
induces at later time points (4–7 days) the expression of a further
set of approximately 200 genes, known as the Enduring Hypoxic
Response (EHR) [16]. Given that several EHR antigens induce
IFN-c and/or IL-2 production in PBMC from M. tb-infected
individuals [14], the EHR may constitute an alternative set of
stage-specific antigens with possible potential for differential
diagnosis in TB infection.
Bovine tuberculosis (BTB) caused by the bacterial pathogen
Mycobacterium bovis (M. bovis) continues to pose a major economic
and animal health problem for the farming community, and the
zoonotic potential of BTB still remains a concern in countries with
little or no control policies. Unlike human M. tb infection, it
remains unclear whether different stages of active versus latent
infection also occur in M. bovis-infected cattle (reviewed in
[17,18,19]). However, the existence of: (i) IFN-c test positive
animals that lack tuberculous lesions [20]; (ii) animals that culture
positive in the absence of lesions [21]; or (iii) IFN-c test positive but
skin test negative animals that later convert to skin test positive and
present with lesions (reviewed in [18], at least support the concept
of BTB latency and subsequent reactivation in cattle. Indeed,
studies have demonstrated reactivation of latent tuberculosis in
humans infected with M. bovis [22]. Thus, if latent BTB does exist
in a similar manner to that in humans, it would pose a serious
complication to the eradication of the disease in cattle.
As mentioned, there is a large interest in developing diagnostic
tests capable of differentiating active versus latent mycobacterial
infections. Although the immunogenicity of stage-specific antigens
has been investigated in human TB patients, no such evaluation
has to date been performed in BTB cases. Thus, the aim of this
present study was to investigate the immunogenicity of the DosR
and EHR antigens using a cattle model of M. bovis infection. Our
results identified several immunogenic EHR antigens, with
responses to one such antigen (Rv0188) associated with a subset
of animals at early stages of infection or in which disease
progression may be limited.
Methods
Ethics Statement
All procedures were conducted within the limits of the Animal
(Scientific Procedures) Act 1986, and approved by the United
Kingdom Home Office and by the Veterinary Laboratories
Agency (VLA) ethical review committee (Home Office Licence
number 70/6775).
Cattle
All animals were housed at the VLA at the time of blood
sampling. In total, heparinised blood samples were obtained from
38 naturally infected, single intradermal comparative cervical
tuberculin (SICCT) test-positive reactors from herds known to
have bovine tuberculosis (BTB) as determined by government
veterinarians of the Animal Health Agency. All TB-reactor
animals were subjected to a detailed post-mortem examination
and the severity of pathology was scored according to a semi-
quantitative system as previously described [23].
Production and preparation of peptides and antigens
Four proteins of the DosR regulon and 29 proteins of the
Enduring Hypoxic Response (Table S1) were selected for antigen
screening experiments. The DosR regulon antigens were selected
based on their immunogenicity in human studies [8]. The
selection of EHR antigens was based on a bioinformatic analysis
(Gideon et al. in preparation). This included consideration of the
fold induction and relative abundance of transcripts at 96 and
168 hours in hypoxic compared to oxygenated axenic cultures,
number and affinity of MHC Class II binding peptides per
molecule, genomic organisation and predicted function. Peptides
representing the selected antigens were commercially produced
(Mimotopes Pty Ltd, Clayton, Australia) as 20-mers overlapping
by 12 amino acids, dissolved in RPMI 1640, formulated into
peptide pools and used at a final concentration of 2–10 mg/ml/
peptide. In total, 57 peptide pools containing a total of 855
peptides were evaluated. Peptides from ESAT-6 and CFP-10 were
formulated to obtain a peptide cocktail as previously described
[24] and were used at a final concentration of 5 mg/ml/peptide.
Bovine tuberculin (PPD-B) was supplied by the Tuberculin
Production Unit at the Veterinary Laboratories Agency, Wey-
bridge, Surrey, UK and was used at a final concentration of
10 mg/ml. Staphylococcal enterotoxin B (SEB; Sigma-Aldrich,
UK) was included as a positive control at a final concentration of
1 mg/ml, while RPMI 1640 alone served as a negative control.
Stimulation of whole blood cultures
Whole blood aliquots (250 ml) were added in duplicate to
antigen in 96-well plates and incubated at 37uC in the presence of
5% CO2 for 24 hours, following which plasma supernatants were
harvested and stored at 280uC until required. The EHR antigens
were screened in two batches, using either 36 or 19 TB reactor
animals.
Measurement of cytokine levels in plasma-supernatant
Quantification of IFN-c in the plasma supernatant was
determined using the Bovigam ELISA kit (Prionics AG, Switzer-
land) according to the manufacturer’s instructions. A result was
considered positive if the optical density at 450 nm (OD450) with
antigen minus the OD450 without antigen (DOD450) was $0.1 in
both of the duplicate wells. IL-2 production was determined by the
ability to sustain proliferation of Concanavalin A (ConA)-induced
lymphoblasts as previously described [25]. A result was considered
positive if the stimulation index (SI; proliferation with antigen
divided by proliferation without stimulus) was greater than 3.
Lastly, simultaneous detection of IFN-c, IL-1b, IL-4, IL-10, IL-12,
MIP-1b and TNF-a was performed using a cytokine multiplex
assay (Meso-Scale Discovery (MSD), Gaithersburg, MD, USA) as
previously described [26].
Statistical analysis
Statistical analysis was performed using GraphPad Instat 3
software (GraphPad Software Inc., USA).
Results
To investigate the immunogenicity of potential stage-specific
antigens, a total of 57 pools of overlapping peptides representing 4
DosR regulon and 29 EHR antigens (Table S1) were screened for
their ability to stimulate an immune response in whole blood from
TB-reactor cattle. As initial experiments revealed that the DosR
regulon proteins were poorly recognized (maximum responder
frequency of 10%, Table S1), we focused our attention on the
panel of EHR antigens (Figure 1). All 29 EHR antigens induced an
IFN-c response in at least one animal, with overall responder
frequencies ranging from 5% up to 54% depending on the
antigen. By contrast, three EHR antigens failed to induce an IL-2
Responses to Rv0188 in Cattle with Low Pathology
PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e21371response in any of the animals studied, while the remaining
antigens were recognized to a variable degree with responder
frequencies ranging from 3% up to 47%. In general, the hierarchy
of response to the EHR antigens were similar irrespective of the
cytokine readout. However, noticeable exceptions to this were
Rv2780, Rv1955 and Rv2022c, which were all placed in the top
ten antigens using IFN-c as a readout but dropped to lower
rankings when IL-2 was used as a readout (Figure 1 and Table S2).
Furthermore, responses in TB-reactor animals were largely IFN-c
biased, as evidenced by higher responder frequencies to the
majority of EHR antigens when using a IFN-c as a readout
compared to IL-2. Having demonstrated a hierarchy in responses
to the panel of EHR antigens, we selected the top 5 most
frequently recognised antigens (Rv0990c, Rv1954c, Rv1284,
Rv0826 and Rv0188) for further analysis.
Although well described in humans, latent mycobacterial
infection in cattle remains poorly classified. In order to define
cattle with possible latent infection, a detailed post mortem
examination was performed on all animals to assess the level of
active disease. The presence of visible lesions in the lymph nodes of
the upper and lower respiratory tract, lung tissue, mesenteric
lymph nodes and all major body organs were recorded and the
severity of pathology was scored for each animal according to a
semi-quantitative system as previously described [23]. A spectrum
of pathology was noted, with scores ranging from 0 (i.e. no visible
lesions) to 55 (multiple lesions). For the purpose of this study, the
animals were classified as having either low pathology (i.e. scores
of less than 10) or high pathology (i.e. scores greater than 10).
Comparison of pathology scores with immune responses to the M.
bovis antigen ESAT-6/CFP-10 cocktail (Figure 2A) revealed
positive IFN-c responses in animals exhibiting either low (upper
left quadrant) or high (upper right quadrant) pathology. However,
positive IFN-c responses to the EHR antigen Rv0188 were only
evident in animals exhibiting low pathology (Figure 2B). Indeed, of
the 12 animals with low pathology scores, six (50%) responded to
Rv0188. In contrast to Rv0188, positive immune responses to the
other four selected EHR antigens (Figure 2C–F) were seen across
the pathology spectrum. Of the animals that responded to ESAT-
6/CFP-10, approximately two-thirds exhibited low pathology
while one-third exhibited high pathology (Figure 3). Similar
frequency distributions were also evident in animals responding to
the EHR antigens Rv0826, Rv1284c, Rv1954c or Rv0990c.
Uniquely, animals responding to Rv0188 were comprised solely of
those with low pathology.
Having shown that positive responses to the EHR antigen
Rv0188 identified cattle with only low pathology scores, we next
investigated the immune profile of these animals in response to
stimulation with other M. bovis antigens (PPD-B or ESAT-6/CFP-
10). The antigen-induced cytokine concentrations for the individ-
ual animals are shown in Figure S1, while the relative cytokine
levels for each group (Rv0188-responders and Rv0188 non-
responders) are depicted in Figure 4. For the majority of cytokines
induced by either PPD-B or ESAT-6/CFP-10, similar relative
levels were seen between the two groups. However, there was a
trend for greater IL-10, IL-1b and IFN-c production in Rv0188
responder animals, which was most evident for PPD-B-driven
responses, where greater IL-1b production in Rv0188 responder
animals achieved statistical significance.
Discussion
The development of a test capable of differentiating active and
latent mycobacterial infections would have major implications to
the management and control of tuberculosis in both public health
and the farming industry. Such tests would likely involve the
detection of immune responses to stage specific antigens, and
several potential candidates have been identified for human-M. tb
infections (including the DosR regulon antigens Rv1733c,
Rv2029c, Rv2627c and Rv2628) based on their preferential
detection in skin test positive individuals that lack clinical signs of
active TB [8,10,11]. Thus, to evaluate if these antigens would be
beneficial in the setting of BTB, we investigated the immunoge-
nicity of Rv1733c, Rv2029c, Rv2627c and Rv2628 using whole
blood cultures from skin test positive, M. bovis infected cattle.
Disappointingly, these antigens were recognised, if at all, by a
substantially lower proportion of skin test positive cattle compared
to skin test positive humans [8]. Given that there is at least a 98%
identity in amino acid sequence for these proteins between M. tb
and M. bovis (strain AF2122/97), it is unlikely that the absence of
T-cell responses in cattle is due to epitope variation between the
two mycobacterial species. Furthermore, RNA transcript levels for
Figure 1. IL-2 and IFN-c response hierarchy after stimulation with EHR antigens. Responses were established using blood samples from at
least 19 TB-reactor animals. IFN-c responses were determined using the BOVIGAM kit, IL-2 responses using a bio-assay (see Materials and Methods).
Results are shown as responder frequencies (proportion of animals tested that gave a positive response). For comparison, the responder frequencies
for ESAT-6/CFP-10 using IFN-c and IL-2 as a readout were 89% and 84% respectively.
doi:10.1371/journal.pone.0021371.g001
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H37Rv) and M. bovis (BCG) grown in vitro in hypoxic conditions
[9]. However, as BCG represents an attenuated form of M. bovis,i t
is unknown if wild type M. bovis strains would exhibit similar gene
profiles in hypoxic conditions. The immunogenicity responses
presented herein are consistent with previous studies demonstrat-
ing lack of responses to DosR regulon antigens in M. bovis BCG
vaccinated mice and humans [9,27]. However, again it remains
unclear in these studies if this lack of response is due to M. bovis
mycobacterium per se (as apposed to M. tb), or as a consequence of
vaccination with an attenuated strain.
In contrast to the DosR regulon antigens, our results
demonstrated that M. bovis-infected cattle more frequently
recognized several EHR antigens. The immunogenicity of three
EHR antigens (Rv1986, Rv2658c and Rv2659c) has also been
recently described in M. tb-infected humans [14]. In this study, the
proportion of individuals recognizing either Rv1986 or Rv2659c
appeared to be greater when IL-2 was used as a readout for T-cell
activation compared to IFN-c. Indeed, almost all individuals
studied mounted an IL-2 response to Rv1986. Furthermore, the
majority of CD4+ T cells recognizing Rv1986 produced only IL-2,
expressed CD27 but lacked CD45RA, leading to the possibility
Figure 2. Comparison of antigen specific IFN-c responses with pathology scores. Antigen induced IFN-c responses were plotted in relation
to the pathology score, with each symbol representing a single animal. Horizontal and vertical dotted lines define the cut offs for IFN-c responders/
non-responders and low pathology/high pathology respectively. Responses to ESAT-6/CFP-10 (A), Rv0188 and Rv1954c (B and E) and Rv0826,
Rv1284c and Rv0990c (C, D and F) were evaluated in 38, 19 and 36 animals respectively.
doi:10.1371/journal.pone.0021371.g002
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CD4+ T-cells. In contrast, our results demonstrated that: (i)
Rv1986 induced IL-2 production in a considerably lower
proportion (14%) of M. bovis-infected cattle; and (ii) immune
responses to the remaining EHR antigens were largely IFN-c
biased. Thus, we speculate that in our TB-reactor cattle, the
majority of EHR antigens studied are targeting effector CD4+ T
cells, although we acknowledge that further flow cytometric data
would be required to support this concept.
Although initially identified during in vitro studies culturing M. tb
in conditions thought to mimic those encountered during latent
mycobacterial infection (e.g. the presence of NO and hypoxia), it is
unlikely that gene products of the DosR regulon and the EHR are
truly restricted to a persistent, non-replicating stage of mycobac-
terial infection [28]. In support, immune responses to some DosR
regulon and EHR antigens have been demonstrated in M. tb-
infected individuals during both latent and active stages of disease
[8,14,29,30]. Our data from M. bovis-infected cattle would also
support this concept, given that animals recognizing the majority
of the immunogenic EHR antigens were not restricted to the low
pathology group (Figure 3).
In human infections, latent TB is defined as evidence of
immunological priming to mycobacterial antigens in the absence
of clinical signs of active disease. Recently, it has been proposed
that in contrast to a bimodal classification of distinct latent and
active stages, TB infection should be viewed as a continuous
spectrum where designations of latent and active disease
correspond to partially overlapping responses to infection [31].
In this context, low pathology is either indicative of early infection
or a robust host response (possibly correlating with latency). In the
setting of M. bovis and cattle, latent mycobacterial infection
remains poorly classified, although it has been suggested that skin
or IFN-c test positive animals that present with no visible lesions
(NVL) may represent latently infected cattle [17]. Unfortunately in
our study, only a small number of animals (3 out of 38) presented
with no visible lesions, making it difficult to make meaningful
comparisons between potentially latent and non-latent animals.
Figure 3. IFN-c responses to Rv0188 were observed only in
animals with low pathology scores. Graph represents the relative
proportion of animals responding to either ESAT-6/CFP-10 (n=34),
Rv0188 (n=6), Rv0826 (n=13), Rv1284 (n=15), Rv1954c (n=9) or
Rv0990c (n=20) that showed either low or high pathology.
doi:10.1371/journal.pone.0021371.g003
Figure 4. Elevated cytokine production in Rv0188-responder animals. Graph shows the relative cytokine levels (mean 6 SEM) in Rv0188
responder animals (n=6, filled bars) and Rv0188 non-responder animals (n=12, open bars). Data are normalized to the mean cytokine concentration
for all animals. Mean PPD-B induced cytokine concentrations were: 2.56 ng/ml (IL-1b); 0.52 ng/ml (IL-4); 18.04 units/ml (IL-10); 36.85 units/ml (IL-12);
64.47 ng/ml (MIP-1b); 15.67 ng/ml (IFN-c); 3.99 ng/ml (TNF-a); and 26.76 SI (IL-2). Mean ESAT-6/CFP-10 induced cytokine concentrations were:
0.65 ng/ml (IL-1b); 0.43 ng/ml (IL-4); 9.44 units/ml (IL-10); 17.28 units/ml (IL-12); 53.77 ng/ml (MIP-1b); 6.90 ng/ml (IFN-c); 2.73 ng/ml (TNF-a); and
11.61 SI (IL-2). * p,0.05 on non-normalised raw data, Unpaired T Test.
doi:10.1371/journal.pone.0021371.g004
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having either low or high pathology. Using this classification, we
demonstrated that Rv0188-specific IFN-c responses were restrict-
ed to the low pathology group, leading us to hypothesize that this
antigen may be an immune target during ‘‘latent’’ BTB. To
explore this, we investigated the immune profile of Rv0188-
responsive animals following stimulation with other M. bovis
antigens (PPD-B or ESAT-6/CFP-10), reasoning that potentially
latent infected animals would exhibit lower levels of cytokine
production (and in particular pro-inflammatory cytokines such as
MIP-1b, TNF-a and IL-1b) than those with active disease. This
reasoning is supported in part by the results of previous studies in
both humans and cattle, demonstrating that greater ESAT-6 and/
or CFP-10-induced immune responses were associated with the
severity of disease pathology [23,29]. However, our results
demonstrated that for the majority of cytokines, ESAT-6/CFP-
10 induced similar levels of production between the Rv0188
responsive and Rv0188 non-responsive groups.
The results of our study may be interpreted in several ways.
Firstly, given that responses to Rv0188 were only seen in animals
with low pathology, it is possible that immune responses targeted
directly to this antigen may contribute to the prevention of disease
progression. Alternatively, responses to Rv0188 may be a
biological marker identifying animals which, by targeting other
mycobacterial proteins, are capable of limiting M. bovis infection.
In support, our results show greater levels of PPD-B-induced IFN-
c and IL-1b production in the Rv0188 responsive animals. Lastly,
it is possible that the animals exhibiting low pathology may
represent cases of recent infection, in which disease progression is
at an early phase. In this scenario, responses to Rv0188 may
identify a subset of animals at early stages of infection. However,
given that the animals studied were natural field reactors, it is
unclear precisely how long these animals have been infected, and
more controlled studies using experimentally infected animals are
required to confirm any possible association between Rv0188
responses and early infection. Whatever the scenario, it most be
noted that only half of the animals in the low pathology group
were responsive to Rv0188, which highlights a limitation in using
responses to this antigen alone in detecting animals with limited
disease progression and/or at early stages of infection.
As previously mentioned, it has been suggested that the
detection of primed cellular immunity to the mycobacterium in
the absence of visible lesions (i.e. NVL) may disclose cattle with
latent M. bovis infection [17]. The current selection criteria for
inclusion of M. bovis-infected animals in our studies is a positive
skin test reaction. However, as evidenced in this study, very few
animals selected in this manner were NVL. It has been shown that
IFN-c positive and/or skin test negative animals can later convert
to skin test positive and present lesions at slaughter (reviewed in
[18]), leading to the speculation that these animals may have been
latently infected when first identified but subsequently underwent
reactivation of the disease. Thus, in future studies, we aim to target
skin test negative but IFN-c positive animals in a hope to identify a
larger proportion of NVL animals required for evaluation of stage-
specific antigens in BTB.
Supporting Information
Table S1 Details of the DosR regulon and EHR proteins
studied.
(XLS)
Table S2 Recognition of the EHR antigens using different
cytokines readouts.
(DOC)
Figure S1 M. bovis antigen-stimulated cytokine pro-
duction in Rv0188-responder and non-responder ani-
mals. Graph shows the levels of PPD-B and ESAT-6/CFP-10-
stimulated cytokine production in Rv0188-responder (closed
circles) and Rv0188-non-responder (open circles) animals. Each
symbol represents a single animal. * p,0.05, Unpaired T Test.
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